Notably, the mutation frequencies of key ICDRGs, such as PI3KA, NLRP3, CASP8, and TLR4, highlight the potential role of genetic alterations in modulating immune responses within the tumor microenvironment. This evidence concerns the gene NLRP3 and neoplasm.